AzTrials
AzTrials

Drone TransportTRANS-AIRGHTNCT05885568

Validation of the Transport of Biological Material by Drone

A study testing blood sampling, drone transportation and car transportation in people with Drone Transport and Biological Samples, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
blood sampling, drone transportation and car transportation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
1 May 2023to 1 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • participants of legal age
  • No contraindication to blood collection
  • Voluntary
  • informed and consenting participants

Who cannot join

  • Impossible to collect sufficient blood volume
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

Other trials in France

About this study

Official title: Validation of the Conditions of Transport of Biological Material by Drone Within the "Groupement Hospitalier de Territoire Somme Littoral Sud"

The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use.

The aim of the project is to validate the transport of biological samples by drone under defined flight conditions between CHAM and CHU Amiens-Picardie

Being tested
blood sampling, drone transportation, car transportation
Keywords
drone transport, biological samples, unmanned aerial system, UAS

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • blood samplingBiological

    Blood sampling from healthy volunteers

  • drone transportationOther

    drone transportation

  • car transportationOther

    car transportation

Study groups in NCT05885568
Study groupRoleWhat they receive
car transportationActive comparatorblood sample tube will be transported by courier (reference treatment)
Receives: Biological: blood sampling; Other: car transportation
drone transportationExperimentalblood sample tube will be prepared for transport by drone (departure from CHAM, 1 hour flight, arrival at CHUAP)
Receives: Biological: blood sampling; Other: drone transportation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation of destination arrival between both transportation types

    Arrival of the load at its destination

    Measured: one hour

  2. Variation of sample temperature during transportation

    maintaining the defined temperatures

    Measured: one hour

  3. Variation of sample allotted time after both transportation types

    Absence of variation of the allotted time of both samples after transportation

    Measured: one hour

  4. Variation of sample degradation after both transportation types

    Absence of physical degradation of both samples after transportation

    Measured: one hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2023
  2. Study start1 May 2023
  3. Primary completion5 Jun 2025
  4. Study completion1 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05885568
Sponsor's protocol ID
PI2023_843_0031
Acronym
TRANS-AIRGHT
Status last verified
Mar 2026
First submitted
9 May 2023
Last updated
31 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing blood sampling, drone transportation and car transportation in people with Drone Transport and Biological Samples, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation of destination arrival between both transportation types (time frame: one hour). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in